secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medpace Holdings, Inc. (MEDP)
CIK:        0001668397
Form:       8-K
Filed at:   2021-07-26T23:59:59+00:00
Accession:  0001564590-21-037944
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medpace Q2 2021 revenue up 35.8% to $278.3M; net income $39.9M ($1.06 EPS)
--------------------------------------------------------------------------

- Net new business awards of $387.6M (+52.5% YoY) produced a 1.39x book-to-bill ratio.
- Backlog grew 29.8% to $1.7B; revenue backlog conversion rate 17.1%.
- EBITDA $47.9M (17.2% margin), up 36.9% YoY; GAAP net income margin 14.3%.
- Direct costs $203.6M vs $148.4M; SG&A $27.0M vs $21.9M in prior-year quarter.
- On a constant currency basis, organic revenue grew 34.4% and EBITDA grew 41.5%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1668397/000156459021037944/0001564590-21-037944-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1668397/000156459021037944/medp-8k_20210726.htm
  HTML page:      https://secwatch.observer/filing/0001564590-21-037944

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer